Liver Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 2 (2006), Issue 2 (February)

1. Deaths on the liver transplant waiting list: an analysis of competing risks.
   Hepatology, 43(2): 345-51. [Abstract] [Full-text]
2. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
   Hepatology, 43(2): 362-72. [Abstract] [Full-text]
3. Effect of perioperative steroids on renal function after liver transplantation.
   Anaesthesia, 61(3): 253-9. [Abstract] [Full-text]
4. Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis.
   Anesth Analg, 102(3): 724-8. [Abstract] [Full-text]
5. Vasotrac arterial blood pressure and direct arterial blood pressure monitoring during liver transplantation.
   Anesth Analg, 102(3): 690-3. [Abstract] [Full-text]
6. Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection.
   Transplantation, 81(4): 620-2. [Abstract] [Full-text]
7. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.
   Transplantation, 81(4): 541-6. [Abstract] [Full-text]
8. A prospective study investigating the cost effectiveness of intraoperative blood salvage during liver transplantation.
   Transplantation, 81(4): 536-40. [Abstract] [Full-text]
9. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition?
   Transplantation, 81(4): 531-5. [Abstract] [Full-text]
10. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Transplantation, 81(4): 525-30. [Abstract] [Full-text]
11. Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.
    J Virol, 80(6): 2654-64. [Abstract] [Full-text]
12. Evaluation of living liver donors with an all-inclusive 3D multi-detector row CT protocol.
    Radiology, 238(3): 900-10. [Abstract] [Full-text]

© 2005-2008 Liver Transplant Research Today. All Rights Reserved.